News Agency
The Times

Alterity Releases Appendix 4C - Q4 FY20 Quarterly Cash Flow Report

  • Written by PR Newswire

Highlights:

  • FDA provides guidance for ATH434 development pathway
  • Company compliant with minimum NASDAQ price
  • End of period cash balance of $9.2M bolstered by $1.5M following issue of shares on 2 July

MELBOURNE, Australia and SAN FRANCISCO, July 31, 2020 /PRNewswire/ -- Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the...

Read more: Alterity Releases Appendix 4C - Q4 FY20 Quarterly Cash Flow Report

Practical Ways to Help Reduce the Risk of Costly Business Disputes

Business disputes have a way of draining time, money and energy that could be better spent running your operation. While not every disagreement can be prevented, many disputes stem from issues that better planning may have reduced or avoided. Taking... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion